ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Therapeutic options for treatment of Female Sexual Dysfunction
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 221801" data-attributes="member: 13851"><p><strong>KEY POINTS</strong></p><p></p><p><em><strong>*Recognition of female sexual dysfunction (FSD) in the clinical setting should be universal, and counseling is an essential part of sexual health care </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*Health care providers (HCPs) should provide information on the full range of therapeutic options, from pharmacotherapies to psychosocial interventions, and on the importance to combine multiple strategies </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*Few pharmacologic therapies are approved for FSD. HCPs can address hypoactive sexual desire disorder by using two psychoactive agents (flibanserin and bremelanotide) in premenopausal women and transdermal testosterone in postmenopausal women </strong></em></p><p><em><strong></strong></em></p><p><strong><em>*Other hormonal therapies (systemic and local) can be used to relieve genitourinary syndrome of menopause/vulvovaginal atrophy associated with sexual pain and eventually improve other dimensions of sexual function</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 221801, member: 13851"] [B]KEY POINTS[/B] [I][B]*Recognition of female sexual dysfunction (FSD) in the clinical setting should be universal, and counseling is an essential part of sexual health care *Health care providers (HCPs) should provide information on the full range of therapeutic options, from pharmacotherapies to psychosocial interventions, and on the importance to combine multiple strategies *Few pharmacologic therapies are approved for FSD. HCPs can address hypoactive sexual desire disorder by using two psychoactive agents (flibanserin and bremelanotide) in premenopausal women and transdermal testosterone in postmenopausal women [/B][/I] [B][I]*Other hormonal therapies (systemic and local) can be used to relieve genitourinary syndrome of menopause/vulvovaginal atrophy associated with sexual pain and eventually improve other dimensions of sexual function[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Therapeutic options for treatment of Female Sexual Dysfunction
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top